My blog buddy Johnny Ancich created this very smart cartoon about cigarettes:
It may not be a bad idea if Steve Jobs gets into the cigarette manufacturing business. Just consider at least these 3 benefits: (more…)
This week, the U.S. Food and Drug Administration (FDA) removed 2 of 3 approved indications for the semi-synthetic macrolide antibiotic telithromycin (Ketek, manufactured by sanofi-aventis).
Ketek loses its indication for (1) acute bacterial sinusitis and (2) acute bacterial exacerbations of chronic bronchitis, often abbreviated as “ABECB”. Ketek remains approved for community acquired pneumonia of mild to moderate severity that is acquired outside of hospitals or long-term care facilities. (more…)
Every day people like you and me can contribute to this antibiotic resistance problem, and we’ve probably all done it in the past, whether we realize it or not. This may not be what we set out to do, but either our lack of awareness or physical desperation leads us to demand antibiotics for illnesses that are not to be treated by antibiotics.
This past week is a perfect example of how antibiotic resistance can start. (more…)